
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🔥 0 minutes ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Develop and execute the U.S. sales strategy supporting the commercialization of CAR-T for autoimmune diseases. • Build and lead a best-in-class specialty sales organization capable of supporting current and future product launches. • Establish commercial objectives, territory design, targeting strategies, and deployment models aligned with corporate goals. • Drive revenue growth while ensuring compliance with all regulatory, legal, and company requirements. • Partner with executive leadership to shape long-term commercial strategy and portfolio planning. • Lead commercialization efforts across the CAR-T ecosystem, including treatment centers, referring physicians, infusion centers, and hospital systems. • Develop strategies to optimize treatment center activation, patient identification, referral pathways, and patient access. • Collaborate closely with Market Access, Cell Therapy Operations, Patient Services, and Medical Affairs to ensure seamless therapy adoption. • Understand and address the complexities associated with cell collection, manufacturing, logistics, reimbursement, and site readiness. • Monitor evolving CAR-T market dynamics, competitive intelligence, and emerging treatment paradigms. • Establish and expand relationships with key neurology stakeholders, including academic centers, comprehensive neuroscience programs, and community neurologists. • Drive customer engagement strategies supporting therapies for autoimmune neurological disorders, neurodegenerative diseases, and other complex neurological conditions. • Develop disease-state education and value-based customer engagement approaches. • Partner with Medical Affairs to ensure effective scientific exchange and customer education initiatives. • Recruit, develop, and retain top-performing regional sales leaders and field sales professionals. • Foster a high-performance culture focused on accountability, collaboration, innovation, and patient impact. • Establish performance expectations, coaching programs, succession planning, and talent development initiatives. • Lead ongoing training efforts focused on disease state expertise, clinical data, reimbursement, and customer engagement excellence. • Partner closely with Market Access, Medical Affairs, Marketing, Commercial Operations, Patient Services, Legal, Compliance, and Finance. • Ensure alignment between field execution and broader commercial strategies. • Support forecasting, business planning, resource allocation, and launch readiness activities. • Provide field insights to inform brand strategy, lifecycle planning, and evidence generation priorities. • Establish and monitor KPIs related to sales performance, account engagement, treatment center activation, patient referrals, and market penetration. • Utilize data analytics to optimize territory performance and resource deployment. • Deliver regular business reviews and strategic recommendations to executive leadership. • Identify opportunities to improve commercial effectiveness and customer experience.
• Bachelor's degree required; advanced degree (MBA, PharmD, PhD, or other relevant graduate degree) preferred. • Minimum 15 years of biopharmaceutical commercial experience. • Minimum 8 years of progressive sales leadership experience, including leading national specialty sales teams. • Demonstrated success launching and commercializing specialty, rare disease, neurology, oncology, immunology, or cell and gene therapies. • Deep understanding of specialty reimbursement, payer dynamics, treatment center engagement, and patient access. • Experience managing field teams supporting highly complex therapies and specialized provider networks. • Proven ability to build, lead, and scale high-performing commercial organizations. • Direct CAR-T, cell therapy, gene therapy, or oncology commercialization experience preferred. • Neurology commercialization experience, particularly within autoimmune or rare neurological disorders preferred. • Experience launching products through limited distribution networks and specialized treatment centers preferred. • Strong understanding of buy-and-bill reimbursement models, specialty pharmacy, specialty distribution, and site-of-care considerations preferred.
• This position is also eligible for bonus • benefits • participation in Company’s stock plan
Apply Now🔥 1 hour ago
Sales Director responsible for leading the sales cycle and customer solutions at Telus Digital. Requires 3+ years of Salesforce consulting and substantial sales experience.
🔥 2 hours ago
Registered Representative responsible for developing advisor and investor relationships in capital raising for distressed real estate investments. Focusing on building partnerships and expanding distribution channels.
🔥 2 hours ago
Director of Sales leading Axon’s Majors Air sales organization in expanding drone technology in public safety. Collaborating with agencies to implement next-generation aerial response programs.
🔥 3 hours ago
Vice President of Sales driving market growth for Duncan Solutions in photo enforcement. Responsible for developing client relationships and leading complex sales cycles.
🔥 13 hours ago
Vice President of Sales at Ardent Global Logistics overseeing revenue growth and commercial strategy. Leading teams and developing high-performing sales talent in logistics and supply chain.